# A Study to Evaluate the Safety and Tolerability of JNJ-67670187 in Healthy Participants

> **NCT03723746** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** JNJ-67670187
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03723746
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-25
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723746, "A Study to Evaluate the Safety and Tolerability of JNJ-67670187 in Healthy Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03723746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*